As discussed in more detail below, many researchers have postulated that FMR1 mRNA gain-of-function toxicity may underlie FXPOI, as is the case for the other PM-associated disorder, fragile X-associated tremor/ataxia syndrome (FXTAS) [25]. Here, FMR1 is linked to fragile X-associated tremor/ataxia syndrome.